226 related articles for article (PubMed ID: 19998053)
21. [The incidence of extended spectrum beta-lactamases in Proteus mirabilis strains isolated in 2007-2009].
Kwiecińska-Piróg J; Bogiel T; Gospodarek E
Przegl Epidemiol; 2010; 64(3):395-8. PubMed ID: 20976952
[TBL] [Abstract][Full Text] [Related]
22. [Drug resistance and proticinogenic types of Proteus mirabilis isolated from urinary tract infections].
Szymaniak L; Aleksandrowicz I; Giedrys-Kalemba S
Med Dosw Mikrobiol; 1999; 51(3-4):323-30. PubMed ID: 10803261
[TBL] [Abstract][Full Text] [Related]
23. The role of extended-spectrum cephalosporin-resistance in recurrent community-onset Enterobacteriaceae urinary tract infections: a retrospective cohort study.
Anesi JA; Lautenbach E; Nachamkin I; Garrigan C; Bilker WB; Omorogbe J; Dankwa L; Wheeler M; Tolomeo P; Han JH;
BMC Infect Dis; 2019 Feb; 19(1):163. PubMed ID: 30764770
[TBL] [Abstract][Full Text] [Related]
24. [Urinary Tract Infections Caused by Community-Acquired Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in a Level III Hospital - A Retrospective Study].
Simões A; Lima M; Brett A; Queiroz C; Chaves C; Oliveira H; Januário L; Rodrigues F
Acta Med Port; 2020 Jul; 33(7-8):466-474. PubMed ID: 31962058
[TBL] [Abstract][Full Text] [Related]
25. Dissemination of Proteus mirabilis isolates harboring CTX-M-14 and CTX-M-3 beta-lactamases at 2 hospitals in Taiwan.
Wu LT; Wu HJ; Chung JG; Chuang YC; Cheng KC; Yu WL
Diagn Microbiol Infect Dis; 2006 Feb; 54(2):89-94. PubMed ID: 16406185
[TBL] [Abstract][Full Text] [Related]
26. Urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing and nonproducing bacteria: a comparative study.
Dayan N; Dabbah H; Weissman I; Aga I; Even L; Glikman D
J Pediatr; 2013 Nov; 163(5):1417-21. PubMed ID: 23919903
[TBL] [Abstract][Full Text] [Related]
27. Molecular drivers of emerging multidrug resistance in Proteus mirabilis clinical isolates from Algeria.
Boudjemaa H; Allem R; Fonkou MDM; Zouagui S; Khennouchi NCEH; Kerkoud M
J Glob Antimicrob Resist; 2019 Sep; 18():249-256. PubMed ID: 30797091
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of bacteremia caused by extended-spectrum beta-lactamase-producing Proteus mirabilis.
Kurihara Y; Hitomi S; Oishi T; Kondo T; Ebihara T; Funayama Y; Kawakami Y
J Infect Chemother; 2013 Oct; 19(5):799-805. PubMed ID: 23371453
[TBL] [Abstract][Full Text] [Related]
29. The impact of production of extended-spectrum β-lactamases on the 28-day mortality rate of patients with Proteus mirabilis bacteremia in Korea.
Ahn JY; Ann HW; Jeon Y; Ahn MY; Oh DH; Kim YC; Kim EJ; Song JE; Jung IY; Kim MH; Jeong W; Ku NS; Jeong SJ; Choi JY; Yong D; Song YG; Kim JM
BMC Infect Dis; 2017 May; 17(1):327. PubMed ID: 28468622
[TBL] [Abstract][Full Text] [Related]
30. Molecular diversity of Proteus mirabilis isolates producing extended-spectrum beta-lactamases in a French university hospital.
Biendo M; Thomas D; Laurans G; Hamdad-Daoudi F; Canarelli B; Rousseau F; Castelain S; Eb F
Clin Microbiol Infect; 2005 May; 11(5):395-401. PubMed ID: 15819867
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and bacteriology of culture-positive urinary tract infection among pregnant women with suspected urinary tract infection at Mbarara regional referral hospital, South-Western Uganda.
Johnson B; Stephen BM; Joseph N; Asiphas O; Musa K; Taseera K
BMC Pregnancy Childbirth; 2021 Feb; 21(1):159. PubMed ID: 33622283
[TBL] [Abstract][Full Text] [Related]
32. Prediction of infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: development of a clinical decision-making nomogram.
García-Tello A; Gimbernat H; Redondo C; Meilán E; Arana DM; Cacho J; Dorado JF; Angulo JC
Scand J Urol; 2018 Feb; 52(1):70-75. PubMed ID: 28893132
[TBL] [Abstract][Full Text] [Related]
33. Primary and Secondary Bacteremia Caused by
Kwiecińska-Piróg J; Skowron K; Gospodarek-Komkowska E
Pol J Microbiol; 2018; 67(4):471-478. PubMed ID: 30550233
[TBL] [Abstract][Full Text] [Related]
34. Bacteremic Urinary Tract Infection Caused by Multidrug-Resistant Enterobacteriaceae Are Associated With Severe Sepsis at Admission: Implication for Empirical Therapy.
Lee YC; Hsiao CY; Hung MC; Hung SC; Wang HP; Huang YJ; Wang JT
Medicine (Baltimore); 2016 May; 95(20):e3694. PubMed ID: 27196480
[TBL] [Abstract][Full Text] [Related]
35. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
[TBL] [Abstract][Full Text] [Related]
36. Childhood urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and empiric therapy.
Uyar Aksu N; Ekinci Z; Dündar D; Baydemir C
Pediatr Int; 2017 Feb; 59(2):176-180. PubMed ID: 27501161
[TBL] [Abstract][Full Text] [Related]
37. Microbiology and Drug Resistance of Pathogens in Patients Hospitalized at the Nephrology Department in the South of Poland.
Michno M; Sydor A; Wałaszek M; Sułowicz W
Pol J Microbiol; 2018; 67(4):517-524. PubMed ID: 30550238
[TBL] [Abstract][Full Text] [Related]
38. Empiric antibiotic therapy in urinary tract infection in patients with risk factors for antibiotic resistance in a German emergency department.
Bischoff S; Walter T; Gerigk M; Ebert M; Vogelmann R
BMC Infect Dis; 2018 Jan; 18(1):56. PubMed ID: 29373965
[TBL] [Abstract][Full Text] [Related]
39. Clinical relevance of Proteus mirabilis in hospital patients: a two year survey.
de Champs C; Bonnet R; Sirot D; Chanal C; Sirot J
J Antimicrob Chemother; 2000 Apr; 45(4):537-9. PubMed ID: 10747835
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Proteus mirabilis bacteremia.
Sohn KM; Kang CI; Joo EJ; Ha YE; Chung DR; Peck KR; Lee NY; Song JH
Korean J Intern Med; 2011 Mar; 26(1):89-93. PubMed ID: 21437168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
